Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carman Alenson currently holds 140,000 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carman Alenson has been a net seller of AGIO stock. They have purchased $0 and sold $773.2K worth of shares.
Carman Alenson's most recent insider trade was on Feb 23, 2026, when they sold 140,000 shares at $0.00 per share.
Carman Alenson serves as Executive at AGIOS PHARMACEUTICALS, INC. (AGIO). They have executed 32 insider transactions totaling $773.2K over their tenure at the company.
Carman Alenson holds the position of Executive at AGIOS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Carman Alenson has shown a selling trading pattern, with $0 in total purchases and $773.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carman Alenson was on Jan 12, 2018, when they sold $161.3K worth of AGIO shares. This transaction involved 2,150 shares at $75.00 per share.
Carman Alenson currently owns 140,000 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carman Alenson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carman Alenson has 32 Form 4 filings on record as an insider at AGIOS PHARMACEUTICALS, INC..
Set alerts for Carman Alenson and 40,000+ other insiders.